StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) revenue by segment

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58−0.02 (-3.83%)

Close on Nov 17, 2026Market cap $13.52MP/E –Yield –

Genenta Science S.p.A. revenue by segment

No segment breakdown reported

Genenta Science S.p.A. does not break out revenue by segment, region or product in the tagged data of its filings for this period type.

See a number that looks wrong?